Endothelial function in health and disease: new insights into the genesis of cardiovascular disease.

[1]  A. Quyyumi,et al.  Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. , 1998, Circulation.

[2]  A. Quyyumi,et al.  Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction. , 1998, Hypertension.

[3]  A. Quyyumi,et al.  Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. , 1997, Journal of the American College of Cardiology.

[4]  A. M. Lefer,et al.  Regulation of P-selectin expression in human endothelial cells by nitric oxide. , 1997, The American journal of physiology.

[5]  A. Quyyumi,et al.  Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. , 1997, Hypertension.

[6]  A. Quyyumi,et al.  Nitric oxide activity in the atherosclerotic human coronary circulation. , 1997, Journal of the American College of Cardiology.

[7]  P. Ganz,et al.  Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. , 1997, Circulation.

[8]  A. Quyyumi,et al.  Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P. , 1997, Circulation.

[9]  J. Stamler,et al.  Biological chemistry of thiols in the vasculature and in vascular-related disease. , 2009, Nutrition reviews.

[10]  J. Ferguson,et al.  American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996. , 1996, Circulation.

[11]  R. Cannon,et al.  Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. , 1996, Circulation.

[12]  A. Yeung,et al.  Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. , 1996, Circulation.

[13]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[14]  A. Keech,et al.  Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. , 1996, The Journal of clinical investigation.

[15]  G. B. John Mancini,et al.  Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction) , 1996 .

[16]  G. Levine,et al.  Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.

[17]  D. Harrison,et al.  REGULATION OF EXPRESSION OF THE ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE , 1996, Clinical and experimental pharmacology & physiology.

[18]  A. Quyyumi,et al.  Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. , 1995, Hypertension.

[19]  A. Quyyumi,et al.  Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. , 1995, The American journal of cardiology.

[20]  V. Schini-Kerth,et al.  Nitric oxide synthases in vascular cells , 1995, Experimental physiology.

[21]  A. Yeung,et al.  Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.

[22]  A. Quyyumi,et al.  Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. , 1995, Circulation.

[23]  R. Busse,et al.  Regulation and functional consequences of endothelial nitric oxide formation. , 1995, Annals of medicine.

[24]  D. Harrison,et al.  Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. , 1995, The Journal of clinical investigation.

[25]  A. Quyyumi,et al.  Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. , 1995, The Journal of clinical investigation.

[26]  A. Quyyumi,et al.  Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. , 1995, Circulation.

[27]  A. Yeung,et al.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.

[28]  W. Weintraub,et al.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.

[29]  A. Quyyumi,et al.  Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. , 1995, The American journal of cardiology.

[30]  P. Ganz,et al.  Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal Women , 1994, Annals of Internal Medicine.

[31]  A. Quyyumi,et al.  Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. , 1994, Journal of the American College of Cardiology.

[32]  M. Sugimachi,et al.  Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans. , 1994, Journal of the American College of Cardiology.

[33]  J. Witztum,et al.  The oxidation hypothesis of atherosclerosis , 1994, The Lancet.

[34]  D. Spiegelhalter,et al.  Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.

[35]  A. Quyyumi,et al.  Acute Vascular Effects of Estrogen in Postmenopausal Women , 1994, Circulation.

[36]  A. Quyyumi,et al.  Selective Loss of Microvascular Endothelial Function in Human Hypercholesterolemia , 1994, Circulation.

[37]  A. Quyyumi,et al.  Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. , 1994, Circulation.

[38]  S. Moncada,et al.  Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. , 1994, Cardiovascular research.

[39]  A. Quyyumi,et al.  Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. , 1994, Journal of the American College of Cardiology.

[40]  D. Harrison,et al.  Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.

[41]  A. Quyyumi,et al.  Effect of Increased Availability of Endothelium‐Derived Nitric Oxide Precursor on Endothelium‐Dependent Vascular Relaxation in Normal Subjects and in Patients With Essential Hypertension , 1993, Circulation.

[42]  A. Quyyumi,et al.  Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. , 1993, Journal of the American College of Cardiology.

[43]  J. Stamler,et al.  NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. , 1993, The Journal of clinical investigation.

[44]  G. Rubanyi,et al.  The role of endothelium in cardiovascular homeostasis and diseases. , 1993, Journal of cardiovascular pharmacology.

[45]  M. Sugimachi,et al.  Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. , 1993, The Journal of clinical investigation.

[46]  A. Quyyumi,et al.  Endothelial Dysfunction in Patients With Chest Pain and Normal Coronary Arteries , 1992, Circulation.

[47]  A. Castaigne,et al.  Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. , 1992, The American journal of cardiology.

[48]  J. Cooke,et al.  L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. , 1992, The Journal of clinical investigation.

[49]  K. Bhoola,et al.  Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.

[50]  H. Drexler,et al.  Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine , 1991, The Lancet.

[51]  A. Yeung,et al.  The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. , 1991, The New England journal of medicine.

[52]  J. Sasaki,et al.  Does superoxide underlie the pathogenesis of hypertension? , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  H. Drexler,et al.  Endothelial Dysfunction of the Coronary Microvasculature Is Associated With Impaired Coronary Blood Flow Regulation in Patients With Early Atherosclerosis , 1991, Circulation.

[54]  P. Kerth,et al.  Effects of perindoprilat on endothelium-dependent relaxations and contractions in isolated blood vessels. , 1991, American journal of hypertension.

[55]  J. Cooke,et al.  Arginine Restores Cholinergic Relaxation of Hypercholesterolemic Rabbit Thoracic Aorta , 1991, Circulation.

[56]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[57]  E. Werner,et al.  Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts , 1990, The Journal of experimental medicine.

[58]  V Ionescu,et al.  [Silent myocardial ischemia]. , 1990, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna.

[59]  A. Yeung,et al.  Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.

[60]  H. Drexler,et al.  Flow-dependent coronary artery dilatation in humans. , 1989, Circulation.

[61]  Z. Katušić,et al.  Superoxide anion is an endothelium-derived contracting factor. , 1989, The American journal of physiology.

[62]  R. Fish,et al.  Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. , 1988, Circulation.

[63]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[64]  P. Vanhoutte,et al.  Endothelium‐dependent hyperpolarization of canine coronary smooth muscle , 1988, British journal of pharmacology.

[65]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[66]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[67]  V. Miller,et al.  Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase. , 1985, The American journal of physiology.

[68]  U. Förstermann,et al.  Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. , 1984, Journal of cardiovascular pharmacology.

[69]  U. Förstermann,et al.  The endothelium-dependent vasodilator effect of acetylcholine: characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolism. , 1984, European journal of pharmacology.

[70]  E. Antman,et al.  Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. , 1983, Circulation.

[71]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.